About
Bi-specific Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
112
By Phase
PHASE1: 2
By Status
TERMINATED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05369000Lead Sponsor
Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer
PHASE1Terminated
96 participants
Started: Jan 17, 2022 · Completed: Jun 18, 2025
NCT04887259Lead Sponsor
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
PHASE1Terminated
16 participants
Started: Jul 12, 2021 · Completed: Sep 6, 2023
Locations (1)
Headquarters
Utrecht, Netherlands
Map
Loading map...